Tuesday, September 8, 2020

Ensysce Biosciences Names New Board Member

San Diego-based Ensysce Biosciences, which is developing opioid pain medication, says it has named Steven R. Martin to its board of directors. Martin is Senior VP and Chief Financial Officer of Aramata Pharmaceuticals. Ensysce said the expansion will help move its new opioid drug glasses, TAAP and MPAR, through clinical development. Ensysce says it is developing 2 new classes of opioid pain medication with abuse and overdose protection.